Loading...
Market
First Country to Approve Human CRISPR Treatment
4
Resolution / Starting Odds
USA • 25%
China • 25%
UK • 25%
Germany • 25%
Global health regulatory body announcements or credible news sources
Story
CRISPR Edits Genes in Fetal Monkeys, Advances Cure for Genetic Diseases
Apr 23, 2024, 01:51 PM
Recent advancements in CRISPR technology have brought the possibility of curing genetic diseases before birth closer to reality, with successful experiments conducted on fetal monkeys. Researchers achieved a scientific milestone by using CRISPR base editing to treat liver disease in these subjects. This breakthrough in genome editing has been recognized as a crucial step towards addressing genetic diseases as a significant public health challenge.
View original story
Similar markets
United States • 25%
European Union • 25%
China • 25%
Japan • 25%
USA • 25%
China • 25%
Germany • 25%
UK • 25%
USA • 20%
UK • 20%
China • 20%
India • 20%
Germany • 20%
USA • 25%
China • 25%
UK • 25%
Germany • 25%
USA • 25%
UK • 25%
China • 25%
India • 25%
USA • 25%
UK • 25%
China • 25%
Canada • 25%
United States • 33%
Canada • 33%
Australia • 33%
USA • 25%
India • 25%
Germany • 25%
Japan • 25%
USA • 25%
Canada • 25%
UK • 25%
Australia • 25%
North America • 25%
Europe • 25%
Asia • 25%
Global (Simultaneous Multi-Region) • 25%